May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Peptide

Argireline

Also known as

Acetyl Hexapeptide-8 · Acetyl Hexapeptide-8 Amide · Acetyl Hexapeptide-3 (legacy INCI / older literature naming — often treated as the same hexapeptide franchise) · AH-8 · AHP-3 / acetylhexapeptide-3 (paper shorthand) · Argireline™ (Lipotec / Lubrizol trade name) · Argireline® Amplified (next-gen franchise peptide — different sequence evolution, not classic AH-8) · Argireline® YOUth (oil-soluble / LipoClear delivery line extension) · Ac-EEMQRR-NH2 · Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 · Argireline peptide · Argireline Solution 10% (mass-market finished-product shorthand, e.g. The Ordinary) · CAS 616204-22-9 (commonly listed for acetyl hexapeptide-8)

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

IdentityAcetyl hexapeptide-8 is a cosmetic peptide in facial serums and creams, discussed for softer expression lines. A topical serum has not demonstrated injectable-Botox effects.
Different formulasOlder names include acetyl hexapeptide-3. Classic Argireline, multi-peptide formulas and newer Amplified or YOUth products should not inherit one another's results.
Notes

Argireline is acetyl hexapeptide-8, a cosmetic peptide people discuss for softer forehead lines, the “11s” between the eyebrows and crow’s feet. Its appeal is a topical option without injections. Reports include visible smoothing, no difference and unwanted reactions; “Botox in a bottle” overstates what a serum has demonstrated.

A six-amino-acid peptide in serums and creams. It was designed to interfere with the protein machinery that releases nerve signals. That laboratory mechanism inspired the muscle-relaxing story; it does not show that a leave-on serum reaches facial muscles or produces injectable-toxin effects. Blanes-Mira et al.: synthetic hexapeptide study (Official context · Accessed 2026-09-30) · Kraeling et al.: in vitro skin penetration (Official context · Accessed 2026-09-30)

The name and the formula both matter. Older discussions call it acetyl hexapeptide-3. Multi-peptide creams, targeted eye products and watery serums differ; newer Argireline Amplified and YOUth brand extensions should not inherit classic-serum results automatically.

Source context — Blanes-Mira et al.: synthetic hexapeptide study: Abstract only; small developer-era study; no safety assurance adopted.

Source context — Kraeling et al.: in vitro skin penetration: Abstract only; nonliving skin and animals, no living-human kinetics.

What people notice

Softer-looking linesSome describe less resting forehead tension, softer morning lines and less concealer creasing, while retaining facial movement.
No change also appearsOne user noticed no difference after more than a year. Human studies also disagree; a small split-face study found no advantage over the HA serum alone.
Notes

Softer lines while retaining expression. Cptn_Cork’s two-month account described less resting forehead tension, with movement and dynamic wrinkles still present. That is a cosmetic appearance report, not proof of muscle paralysis. Two months 10% Argireline on forehead lines (Personal report · Accessed 2026-09-30)

Subtle smoothing can be enough for some people. The existing community record includes less concealer creasing and softer morning lines. People also discuss maintenance between toxin appointments, but those routines cannot isolate a serum’s contribution.

Consistency does not guarantee a response. macelisa reported more than a year of use, once or twice daily, without noticing a difference. A separate sagging thread includes a no-benefit account. Nonresponse should not automatically be called incorrect application. Argireline: is it second best to Botox? (Community discussion · Accessed 2026-09-30) · Does Argireline cause sagging skin? (Community discussion · Accessed 2026-09-30)

Human studies give mixed support. Blanes-Mira’s early study reported up to 30% wrinkle-depth reduction after 30 days with a 10% emulsion. Henseler’s 19-person, four-week split-face study found no significant advantage over the hyaluronic-acid serum without Argireline. Neither settles every formulation. Blanes-Mira et al.: synthetic hexapeptide study (Official context · Accessed 2026-09-30) · Henseler: Argireline serum and Visia analysis (Official context · Accessed 2026-09-30)

Source context — Two months 10% Argireline on forehead lines: Uncontrolled recollection; photo link not inspected.

Source context — Argireline: is it second best to Botox?: Co-products and ageing confound comparisons; some replies unavailable.

Source context — Does Argireline cause sagging skin?: No-sagging testimonial is not a long-term safety study.

Source context — Blanes-Mira et al.: synthetic hexapeptide study: Abstract only; small developer-era study; no safety assurance adopted.

Source context — Henseler: Argireline serum and Visia analysis: Full article text inspected; one serum, small sample, other cosmetics permitted.

Doses people talk about

5–10% solution labelsCommercial-solution percentages dominate discussion, especially 10% retail serum. They do not mean 5–10% pure peptide; larger 15–20% labels do not establish more delivered peptide.
Application amountsOne account used about one-third of an uncalibrated pipette twice daily. Older routines describe a few drops to expression zones, with once-daily variants.
Notes

5–10% commercial-solution talk; 10% retail serum dominates these accounts. These are formulation labels, not injected milligrams. The preserved record also includes 15–20% marketplace claims; a larger headline percentage does not establish more peptide delivered into skin.

“Solution percentage” and pure-peptide percentage are different. Commercial user guides explain that a dilute trade solution is added to a finished formula. The exact stock strength matters, so a retail “10%” label cannot be read as 10% pure peptide or converted into a trustworthy microgram dose. Argireline topical dosage chart (Community guide · Accessed 2026-09-30)

One reported application: about one-third pipette, twice daily. Cptn_Cork described that amount per application, morning and evening. The pipette was not calibrated into millilitres or peptide mass. The older record includes a few drops to expression zones and once-daily variants; these are separate routines. Two months 10% Argireline on forehead lines (Personal report · Accessed 2026-09-30)

Source context — Argireline topical dosage chart: Commercial-facing guide with AI promotion; not independent efficacy or assay evidence.

Source context — Two months 10% Argireline on forehead lines: Uncontrolled recollection; photo link not inspected.

Half-life, onset & duration

Felt or visible onsetReports range from immediate smoothing with patches to finer lines around a month with Matrixyl. Older photo checkpoints are 2–3 and 3–4 weeks.
Visible durationOne patch-and-serum user described a workday of smoothing shrinking to six hours, then three, then little effect. No dependable single-application window is established.
Half-lifeHuman topical half-life is unknown here. The circulated four-hour estimate and a 24-hour laboratory skin-recovery experiment do not establish it.
Notes

Immediate smoothing and a month-long change are different reports. The patch-and-serum user described improvement after application; abu_nawas reported a finer line after about a month with Matrixyl. Neither separates peptide effects from patches, hydration or co-products. Argireline solution stopped working (Personal report · Accessed 2026-09-30) · Argireline: is it second best to Botox? (Community discussion · Accessed 2026-09-30)

Older checkpoints: 2–3 weeks, then about 3–4 weeks. The preserved community notes describe photo comparisons and subtle morning-crease changes, with some people remaining unchanged. These are observation windows, not an onset deadline.

A workday, then 6 hours, then 3 hours, then little effect—in one account. Pickles_The_Cat_1234 described this changing course while also using overnight forehead patches; copper peptides were added later. It does not establish a predictable single-application window or prove tolerance. Argireline solution stopped working (Personal report · Accessed 2026-09-30)

Human topical half-life is unknown; “about 4 hours” is an unsupported circulated estimate. Ground Truth’s peptide summary lists ~4 h without identifying a route-specific human clearance measurement. Its vendor-directory format is not a pharmacokinetic study. Morning/evening application and hours of visible smoothing do not validate that number. Ground Truth Argireline peptide summary (Community guide · Accessed 2026-09-30)

24-hour skin recovery is not half-life. Kraeling applied 2 mg of formulation/cm² in a laboratory model using human cadaver and guinea-pig skin. Human recovery was 0.22% in the outer skin layer and 0.01% in epidermis, with none detected in dermis or underlying fluid. Those figures do not measure living-human clearance. Kraeling et al.: in vitro skin penetration (Official context · Accessed 2026-09-30)

Source context — Argireline solution stopped working: Patches and later copper serum confound timing; exact publication date not confirmed.

Source context — Argireline: is it second best to Botox?: Co-products and ageing confound comparisons; some replies unavailable.

Source context — Ground Truth Argireline peptide summary: Commercial-facing aggregator; no human measurement supplied for timing. Inferred microgram figures excluded.

Source context — Kraeling et al.: in vitro skin penetration: Abstract only; nonliving skin and animals, no living-human kinetics.

Cycles people discuss

Comparison windowsPeople discuss 3–4 weeks, sometimes a second block totaling about 6–8 weeks, or ongoing daily skincare. No established break or reset calendar emerges.
Notes

3–4 weeks to compare; sometimes a second block, about 6–8 weeks total. Those windows remain in the older community record. Other users continue for months: one reviewed thread contains a report of more than a year without perceived sagging. Ongoing skincare differs from a fixed injection cycle. Does Argireline cause sagging skin? (Community discussion · Accessed 2026-09-30)

No established break calendar. The preserved notes include event-related restarts and both pauses and continued use around Botox appointments. Off periods are preferences; no inspected account establishes an optimal course or reset interval.

Source context — Does Argireline cause sagging skin?: No-sagging testimonial is not a long-term safety study.

Stacks

Skincare pairingsMatrixyl, HA/glycerin, niacinamide, moisturizer, SPF and copper-peptide blends appear. SNAP-8, Leuphasyl and Syn-Ake are sometimes combined; mixture results are not Argireline-only results.
Separate-session routinesOlder accounts use morning peptides with night retinoids or alternate sessions, keeping direct acids and pure vitamin C apart. Product-compatibility claims do not prove every mixture deactivates it.
Notes

Stacks make credit difficult to assign. The preserved record mixes Argireline with Matrixyl, HA/glycerin, niacinamide, moisturizers, sunscreen, retinoids and copper-peptide blends. SNAP-8, Leuphasyl and Syn-Ake are also compared or combined. Outcomes from these mixtures are not Argireline-only results.

Acid and vitamin-C separation is discussed; retinoid routines vary. Older notes describe morning peptides/night retinoids or alternate sessions, with direct acids and pure vitamin C kept apart. These are product-compatibility discussions, not proof that every combination deactivates the peptide.

Watch for

Skin and head symptomsReports include bumps, dryness, stinging, flaking, eye watering and headache/pressure. Worse lines and sagging fears have competing accounts; no single ingredient cause is established.
Invasive useA case report describes serious infection after facial Argireline injections. A cosmetic serum is not an injection preparation; that case does not describe ordinary intact-skin use.
Notes

Dryness, bumps and irritation can outweigh smoother lines. One poster developed forehead bumps after adding Argireline with Matrixyl; a respondent stopped after a similar reaction. That does not identify the responsible ingredient. The Ordinary currently labels its serum alcohol-free, so watery texture should not automatically be blamed on alcohol. Forehead bumps after Argireline and Matrixyl (Community discussion · Accessed 2026-09-30) · The Ordinary: Argireline Solution 10% (Official context · Accessed 2026-09-30)

Sting, flaking and eye watering also appear in the older record. Prior community notes include dry patches, tightness, hives or dermatitis and eye-area irritation. Those reports concern whole formulas and placement, not a confirmed peptide-only reaction or a reason to push through symptoms.

Headache reports deserve their own place. An allergy-thread author reported headache, sinus/ear pressure and throat/neck discomfort that eased during a pause and returned after reuse. The account does not diagnose an allergy or prove causation; the author stopped and switched to Matrixyl. Argireline side effects or allergy? (Community discussion · Accessed 2026-09-30)

Worse-looking lines and sagging fears are distinct. catmami17 later liked the serum after initially seeing worse lines, speculating about dryness or too much product; other commenters stopped. Another thread contains a year-long no-sagging account. These competing observations establish neither inevitable damage nor universal reassurance. Can an Argireline solution make wrinkles worse? (Community discussion · Accessed 2026-09-30) · Does Argireline cause sagging skin? (Community discussion · Accessed 2026-09-30)

A cosmetic serum is not an injection preparation. Chen’s case report documented Mycobacterium abscessus infection after facial Argireline injections, with nodules and abscesses after a week. The danger concerns invasive use; it is not evidence of that infection from ordinary intact-skin application. Chen et al.: infection after facial injection (Official context · Accessed 2026-09-30)

Source context — Forehead bumps after Argireline and Matrixyl: Two products added; no confirmed cause or diagnosis.

Source context — The Ordinary: Argireline Solution 10%: Commercial manufacturer label; current regional formula may differ from older bottles.

Source context — Argireline side effects or allergy?: Self-reported symptom trajectory; cannot diagnose allergy.

Source context — Can an Argireline solution make wrinkles worse?: Explanations remain user speculation; co-routines differ.

Source context — Does Argireline cause sagging skin?: No-sagging testimonial is not a long-term safety study.

Source context — Chen et al.: infection after facial injection: Abstract only; case report cannot estimate incidence or topical risk.

Full notes

Argireline is acetyl hexapeptide-8, a cosmetic peptide people discuss for softer forehead lines, the “11s” between the eyebrows and crow’s feet. Its appeal is a topical option without injections. Reports include visible smoothing, no difference and unwanted reactions; “Botox in a bottle” overstates what a serum has demonstrated.

What Argireline actually is

  • A six-amino-acid peptide in serums and creams. It was designed to interfere with the protein machinery that releases nerve signals. That laboratory mechanism inspired the muscle-relaxing story; it does not show that a leave-on serum reaches facial muscles or produces injectable-toxin effects. Official context Official context
  • The name and the formula both matter. Older discussions call it acetyl hexapeptide-3. Multi-peptide creams, targeted eye products and watery serums differ; newer Argireline Amplified and YOUth brand extensions should not inherit classic-serum results automatically. Community

Benefits people seek and report

  • Softer lines while retaining expression. Cptn_Cork’s two-month account described less resting forehead tension, with movement and dynamic wrinkles still present. That is a cosmetic appearance report, not proof of muscle paralysis. Personal report
  • Subtle smoothing can be enough for some people. The existing community record includes less concealer creasing and softer morning lines. People also discuss maintenance between toxin appointments, but those routines cannot isolate a serum’s contribution. Community Community
  • Human studies give mixed support. Blanes-Mira’s early study reported up to 30% wrinkle-depth reduction after 30 days with a 10% emulsion. Henseler’s 19-person, four-week split-face study found no significant advantage over the hyaluronic-acid serum without Argireline. Neither settles every formulation. Official context Official context

Doses: topical concentrations and amounts

These describe discussion, not a personal regimen. A cosmetic percentage and drops per application are different quantities.

  • 5–10% commercial-solution talk; 10% retail serum dominates these accounts. These are formulation labels, not injected milligrams. The preserved record also includes 15–20% marketplace claims; a larger headline percentage does not establish more peptide delivered into skin. Community
  • One reported application: about one-third pipette, twice daily. Cptn_Cork described that amount per application, morning and evening. The pipette was not calibrated into millilitres or peptide mass. The older record includes a few drops to expression zones and once-daily variants; these are separate routines. Personal report Community
  • “Solution percentage” and pure-peptide percentage are different. Commercial user guides explain that a dilute trade solution is added to a finished formula. The exact stock strength matters, so a retail “10%” label cannot be read as 10% pure peptide or converted into a trustworthy microgram dose. Community Community guide

Half-life

  • Human topical half-life is unknown; “about 4 hours” is an unsupported circulated estimate. Ground Truth’s peptide summary lists ~4 h without identifying a route-specific human clearance measurement. Its vendor-directory format is not a pharmacokinetic study. Morning/evening application and hours of visible smoothing do not validate that number. Community guide

Onset: when people notice something

  • Immediate smoothing and a month-long change are different reports. The patch-and-serum user described improvement after application; abu_nawas reported a finer line after about a month with Matrixyl. Neither separates peptide effects from patches, hydration or co-products. Personal report Reddit
  • Older checkpoints: 2–3 weeks, then about 3–4 weeks. The preserved community notes describe photo comparisons and subtle morning-crease changes, with some people remaining unchanged. These are observation windows, not an onset deadline. Community

Duration: how long smoothing lasts

  • A workday, then 6 hours, then 3 hours, then little effect—in one account. Pickles_The_Cat_1234 described this changing course while also using overnight forehead patches; copper peptides were added later. It does not establish a predictable single-application window or prove tolerance. Personal report
  • Lines noticed after a two-week holiday are not a measured washout. flanface87 had initially seen little difference, then noticed forehead lines after travelling without the serum. The user explicitly questioned whether stopping or ordinary ageing explained it. Reddit

Cycles and time off

  • 3–4 weeks to compare; sometimes a second block, about 6–8 weeks total. Those windows remain in the older community record. Other users continue for months: one reviewed thread contains a report of more than a year without perceived sagging. Ongoing skincare differs from a fixed injection cycle. Community Reddit
  • No established break calendar. The preserved notes include event-related restarts and both pauses and continued use around Botox appointments. Off periods are preferences; no inspected account establishes an optimal course or reset interval. Community

Good to know

  • Dryness, bumps and irritation can outweigh smoother lines. One poster developed forehead bumps after adding Argireline with Matrixyl; a respondent stopped after a similar reaction. That does not identify the responsible ingredient. The Ordinary currently labels its serum alcohol-free, so watery texture should not automatically be blamed on alcohol. Reddit Official context
  • Sting, flaking and eye watering also appear in the older record. Prior community notes include dry patches, tightness, hives or dermatitis and eye-area irritation. Those reports concern whole formulas and placement, not a confirmed peptide-only reaction or a reason to push through symptoms. Community
  • Headache reports deserve their own place. An allergy-thread author reported headache, sinus/ear pressure and throat/neck discomfort that eased during a pause and returned after reuse. The account does not diagnose an allergy or prove causation; the author stopped and switched to Matrixyl. Reddit
  • A cosmetic serum is not an injection preparation. Chen’s case report documented Mycobacterium abscessus infection after facial Argireline injections, with nodules and abscesses after a week. The danger concerns invasive use; it is not evidence of that infection from ordinary intact-skin application. Official context
  • Special-population safety is not established by testimonials. Pregnancy and medical-condition questions remain in the prior discussion. No dedicated safety evidence for those groups was inspected here. Brand directions restrict use to unbroken skin and advise stopping for irritation. Community Official context

From community discussion

  • Watery feel, occasional tightness, no reliable “freeze.” The older record describes quick absorption and temporary smoothing rather than a distinctive whole-body feeling. A cosmetic film or smoother makeup does not identify a nerve effect. Community
  • Consistency does not guarantee a response. macelisa reported more than a year of use, once or twice daily, without noticing a difference. A separate sagging thread includes a no-benefit account. Nonresponse should not automatically be called incorrect application. Reddit Reddit
  • Layering debates are about routines, not proven delivery. A Looksmaxxing user guide favors clean, dry skin, a thin serum before heavier products and Matrixyl/HA pairing. It repeats a muscle-target story as established; those preferences do not demonstrate delivery to nerves. Looksmaxxing forum
  • Stacks make credit difficult to assign. The preserved record mixes Argireline with Matrixyl, HA/glycerin, niacinamide, moisturizers, sunscreen, retinoids and copper-peptide blends. SNAP-8, Leuphasyl and Syn-Ake are also compared or combined. Outcomes from these mixtures are not Argireline-only results. Community
  • Acid and vitamin-C separation is discussed; retinoid routines vary. Older notes describe morning peptides/night retinoids or alternate sessions, with direct acids and pure vitamin C kept apart. These are product-compatibility discussions, not proof that every combination deactivates the peptide. Community Community
  • Worse-looking lines and sagging fears are distinct. catmami17 later liked the serum after initially seeing worse lines, speculating about dryness or too much product; other commenters stopped. Another thread contains a year-long no-sagging account. These competing observations establish neither inevitable damage nor universal reassurance. Reddit Reddit
  • Cheap maintenance still takes daily effort. Older notes compare modest-cost serums with repeated toxin appointments and describe switching vehicles or simplifying the routine when gains seem unclear. Convenience, cost and subtle appearance changes help explain interest even without a Botox-like result. Community Community

What the formal numbers mean

  • 24-hour skin recovery is not half-life. Kraeling applied 2 mg of formulation/cm² in a laboratory model using human cadaver and guinea-pig skin. Human recovery was 0.22% in the outer skin layer and 0.01% in epidermis, with none detected in dermis or underlying fluid. Those figures do not measure living-human clearance. Official context
  • 0.005% refers to the ingredient in a cosmetic safety assessment. The 2025 Cosmetic Ingredient Review panel found the available data sufficient for assessed cosmetic uses up to 0.005%, and insufficient above that. This is not an application target or a safety guarantee for products carrying larger trade-solution percentages. Official context

Open in the directory ↗All STUDresearch topics →